XKR7
XK-related protein 7
Also known as: C20orf159, dJ310O13.4, XKR7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5GH72
- Gene
- XKR7
- Ensembl
- ENSG00000260903
- Chromosome
- 20
- Canonical length
- 579 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in apoptotic process involved in development; engulfment of apoptotic cell; and phosphatidylserine exposure on apoptotic cell surface. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
579 residues, UniProt reviewed canonical sequence.
>Q5GH72|XKR7
1 MAAKSDGAAA SASPDPEGAA GGARGSAGGR GEAAAAAGPP GVVGAGGPGP RYELRDCCWV
61 LCALLVFFSD GATDLWLAAS YYLQNQHTYF SLTLLFVLLP SLVVQLLSFR WFVYDYSEPA
121 GSPGPAVSTK DSVAGGAAIS TKDSAGAFRT KEGSPEPGPQ PAPSSASAYR RRCCRLCIWL
181 LQTLVHLLQL GQVWRYLRAL YLGLQSRWRG ERLRRHFYWQ MLFESADVSM LRLLETFLRS
241 APQLVLQLSL LVHRGGAPDL LPALSTSASL VSLAWTLASY QKVLRDSRDD KRPLSYKGAV
301 AQVLWHLFSI AARGLAFALF ASVYKLYFGI FIVAHWCVMT FWVIQGETDF CMSKWEEIIY
361 NMVVGIIYIF CWFNVKEGRS RRRMTLYHCI VLLENAALTG FWYSSRNFST DFYSLIMVCV
421 VASSFALGIF FMCVYYCLLH PNGPMLGPQA PGCIFRKASE PCGPPADAIT SPPRSLPRTT
481 GAERDGASAG ERAGTPTPPV FQVRPGLPPT PVARTLRTEG PVIRIDLPRK KYPAWDAHFI
541 DRRLRKTILA LEYSSPATPR LQYRSVGTSQ ELLEYETTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against XKR7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 15 nTPM
- retina: 4.4 nTPM
- pituitary gland: 4.1 nTPM
- cerebral cortex: 2 nTPM
- hypothalamus: 0.8 nTPM
- amygdala: 0.5 nTPM
Single-cell type
- retinal bipolar cells: 20 nCPM
- thyrotrophs: 19 nCPM
- lactotrophs: 18 nCPM
- brain excitatory neurons: 16 nCPM
- cone photoreceptor cells: 15 nCPM
- rod photoreceptor cells: 14 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 21 nTPM
- cerebral cortex: 10 nTPM
- white matter: 6.2 nTPM
- basal ganglia: 5.4 nTPM
- hypothalamus: 4.2 nTPM
- amygdala: 4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about XKR7.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 89 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 1.57
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process involved in development
- engulfment of apoptotic cell
- phosphatidylserine exposure on apoptotic cell surface
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads XKR7 as an antibody target. Whether an autoantibody or antibody against XKR7 could matter depends on whether native XKR7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
XKR7 is annotated at the cell surface, where native XKR7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label XKR7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...